Abstract
We studied leukemia-free (LFS) and overall survival (OS) in children with acute myeloid (AML, n = 790) and acute lymphoblastic leukemia (ALL, n = 1096) who underwent transplantation between 2000 and 2010 and who survived for at least 1 year in remission after related or unrelated donor transplantation. Analysis of patient-, disease-, and transplantation characteristics and acute and chronic graft-versus-host disease (GVHD) was performed to identify factors with adverse effects on LFS and OS. These data were used to develop risk scores for survival. We did not identify any prognostic factors beyond 4 years after transplantation for AML and beyond 3 years for ALL. Risk score for survival for AML includes age, disease status at transplantation, cytogenetic risk group, and chronic GVHD. For ALL, the risk score includes age at transplantation and chronic GVHD. The 10-year probabilities of OS for AML with good (score 0, 1, or 2), intermediate (score 3), and poor risk (score 4, 5, 6, or 7) were 94%, 87%, and 68%, respectively. The 10-year probabilities of OS for ALL were 89% and 80% for good (score 0 or 1) and poor risk (score 2), respectively. Identifying children at risk for late mortality with early intervention may mitigate some e...Continue Reading
References
Jul 1, 1999·The New England Journal of Medicine·G SociéJ P Klein
Oct 16, 1999·British Journal of Haematology·K WheatleyH Walker
Jan 19, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G SociéM M Horowitz
Nov 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary EapenJohn E Wagner
Jan 13, 2006·The New England Journal of Medicine·Ching-Hon Pui, William E Evans
Jan 24, 2007·Biometrical Journal. Biometrische Zeitschrift·Thomas A Gerds, Martin Schumacher
Jun 15, 2007·Lancet·Mary EapenJohn E Wagner
Aug 3, 2007·Blood·Smita BhatiaDaniel J Weisdorf
Sep 6, 2007·Blood·Stephanie J LeeClaudio Anasetti
Sep 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy J BuninMary Eapen
Jul 15, 2009·Bone Marrow Transplantation·Y R Abou-MouradJ C Lavoie
Oct 15, 2009·Hematology/oncology Clinics of North America·Krzysztof MrózekPeter D Aplan
Jan 13, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul J MartinBarry E Storer
Jul 31, 2010·Blood·Peter J ShawMichael A Pulsipher
Apr 6, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John R WingardGérard Socié
Sep 10, 2011·British Journal of Haematology·Brenda E S GibsonUNKNOWN United Kingdom Childhood Leukaemia Working Group and the Dutch Childhood Oncology Group
Aug 11, 2012·Blood·Ursula CreutzigUNKNOWN AML Committee of the International BFM Study Group
Sep 11, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephanie J LeeDaniel J Weisdorf
Aug 28, 2014·Blood·Joseph PidalaClaudio Anasetti
Citations
Apr 4, 2020·Pediatric Dermatology·Maria Teresa García-RomeroAlberto Olaya-Vargas
Apr 7, 2019·Blood Advances·Amy K KeatingJaap Jan Boelens
May 31, 2018·Blood Advances·Andrew C HarrisJohn E Levine
Aug 25, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel A KeeslerMary Eapen
Sep 24, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Troy C LundMary Eapen
Sep 5, 2021·Journal of Cancer Research and Clinical Oncology·Cécile PochonMarie-Thérèse Rubio